Relative Afferent Pupillary Defect (RAPD)

Key Points at a Glance

RAPD is not an independent “disease” but a “clinical sign” detected by the swinging flashlight test.
Indicates the presence of unilateral or asymmetric damage to the retina or optic nerve (anterior to the lateral geniculate body) on one side.
RAPD is not positive in opacities of the ocular media such as cataracts, and in principle, it is not positive in lesions posterior to the optic chiasm either.
Since the inter-examiner disagreement rate for manual testing is as high as 39%, objective evaluation with a digital pupillometer is useful for improving accuracy.
There is no specific treatment for RAPD itself; treatment is directed at the underlying cause.
In orbital compartment syndrome, which requires urgent intervention, a positive RAPD is an indication for emergency decompression.

1. What is Relative Afferent Pupillary Defect (RAPD)?

Relative afferent pupillary defect (RAPD) is a clinical sign detected by the swinging flashlight test, in which light is alternately shone into each eye. It is used almost synonymously with Marcus Gunn pupil. It is an important finding indicating the presence of unilateral or asymmetric damage to the retina or optic nerve (anterior to the lateral geniculate body) on one side.

RAPD is one of the most basic ophthalmic examinations performed by neurologists, ophthalmologists, and optometrists, and is useful for the early diagnosis of many important diseases such as optic neuritis and multiple sclerosis. Misdiagnosis of optic nerve disease in the early stages can lead to irreversible vision loss.

Important principles are shown below.

Bilateral and symmetric cases are not RAPD: Equal damage on both sides does not produce asymmetry, resulting in bilateral APD.
Opacities of the ocular media do not cause a positive RAPD: Lesions that block light entry, such as cataracts or vitreous hemorrhage, do not cause a positive RAPD if the pupillary afferent pathway is not directly damaged.
Lesions posterior to the optic chiasm do not generally cause a positive RAPD: However, because the optic tract contains more crossed fibers than uncrossed fibers, optic tract lesions may cause a mild RAPD in the contralateral eye.

Q Does the presence of a cataract affect the RAPD test result?

Opacities of the ocular media such as cataracts reduce the amount of light entering the eye, but do not directly damage the pupillary afferent pathway, so RAPD is not positive. If RAPD is positive even with severe cataract, there is a high possibility of underlying optic nerve or retinal disease.

2. Main Symptoms and Clinical Findings

Subjective Symptoms

RAPD is not a “symptom” perceived by the patient, but a “sign” detected by the physician through examination. What the patient perceives are symptoms caused by the underlying disease, which commonly include the following.

Decreased visual acuity: Occurs in optic neuritis, ischemic optic neuropathy, etc.
Eye pain or pain with eye movement: Seen in about 60% of optic neuritis cases.
Visual field defects: Central scotoma, centrocecal scotoma, etc.
Color vision abnormalities: Particularly dulling of red (characteristic of optic neuritis).

Clinical Signs (Findings Confirmed by Physician Examination)

Pupillary dilation during the swinging flashlight test: The pupil dilates (or the degree of constriction is reduced) despite light being shone into the affected eye. This is the essential finding of a positive RAPD.
Diminished direct light reflex: On the affected side, the speed of pupillary constriction slows and the response amplitude decreases.
Anisocoria does not occur: Because the abnormality is in the afferent pathway, the direct and consensual responses are nearly equal under binocular open conditions, so resting anisocoria does not occur.
Differentiation from efferent pathway disorders: In efferent pathway disorders such as oculomotor nerve palsy, the affected eye is constantly dilated and does not constrict when light is shone. In RAPD, both eyes constrict when the healthy eye is illuminated (because the efferent pathway is normal).

3. Causes and Risk Factors

Optic Nerve Causes

Demyelinating optic neuritis: Most common in MS, NMOSD, and MOGAD.

Ischemic optic neuropathy: NA-AION, giant cell arteritis.

Compressive optic neuropathy: Thyroid eye disease, orbital tumors, pituitary lesions.

Glaucoma: When there is severe asymmetric damage.

Retinal and Other Causes

Ischemic retinal diseases: CRVO, CRAO, etc.

Retinal detachment: Macular detachment or involving two or more quadrants.

Intraocular tumors: Metastatic lesions, melanoma.

Amblyopia: Severe cases (visual acuity 20/400 or worse).

Optic nerve causes are the most common. Representative diseases are listed below.

Demyelinating optic neuritis: Peak age 15–45 years, more common in women.
- MOG-IgG-associated optic neuritis (MOGAD): Ocular pain with eye movement 86%, optic disc edema 86%. Visual loss is severe but recovery is good (poor prognosis with visual acuity 20/200 or worse in 5–14%) ²⁾.
- Anti-AQP4 antibody-positive optic neuritis: Approximately 10% of idiopathic optic neuritis. Female-to-male ratio 9:1. Steroid-resistant and poor prognosis.
Metastatic optic neuropathy: Orbital metastasis from breast cancer, etc. Optic nerve metastasis accounts for 4.5% of ocular metastases. Onset occurs on average 4.5–6.5 years after primary diagnosis ¹⁾.
Orbital compartment syndrome: Positive RAPD is an indication for emergency decompression. In a case of postpartum lateral rectus hematoma, positive RAPD prompted lateral canthotomy and hematoma evacuation, with visual acuity improving from no light perception (NPL) to 6/6 ³⁾.
Choroidal tuberculoma: Intraocular lesions associated with miliary tuberculosis can also cause RAPD ⁴⁾.
Drug-induced optic neuropathy: Caused by ethambutol, etc. Contrast-enhanced MRI shows no enhancement of the optic nerve.
Nutritional optic neuropathy: Vitamin B12 and B1 deficiency.

Q Will RAPD be positive even if both eyes have the same degree of retinal disease?

RAPD does not appear in symmetric bilateral retinal disease. If there is no difference in light input between the left and right eyes, pupillary dilation does not occur during the swinging flashlight test. It is important to understand that RAPD is a test that detects “left-right difference (asymmetry).“

4. Diagnosis and Examination Methods

Swinging Flashlight Test

Can be performed with a single penlight. No special equipment is required, and it is simple, quick, and of high diagnostic value.

Procedure details:

Perform in a dimly lit room after dark adaptation.
Have the patient fixate on a distant target.
Shine a bright penlight (or handheld slit lamp) from below alternately into each eye for about 2 seconds.
Observe only the pupil of the eye being illuminated.
Normal: When quickly moving to the other eye, adequate constriction is similarly observed.
RAPD positive: When light is moved to the affected eye, the light reflex does not occur and both eyes dilate (or the degree of constriction is clearly reduced).

Note: It is important to direct the light source at the same angle (preferably from the front) for both eyes. Oblique illumination can easily cause false positives.

Limitations of the test

The inter-examiner disagreement rate for manual assessment is as high as 39%. Detection of subtle differences between the eyes becomes difficult in cases of dark iris color, anisocoria, small pupils, or efferent pathway disorders.

Quantification of RAPD

Neutral density (ND) filter method: Perform the swinging flashlight test with an ND filter placed in front of the healthy eye, and quantify the RAPD by the filter density at which it disappears. This is also useful for evaluating treatment response.
Subjective grading: Grading based on the initial constriction and subsequent redilation of each pupil. It is considered to have quantification accuracy equivalent to the ND filter method.

Digital pupillography

Objective and quantitative evaluation using infrared video devices is possible, compensating for the limitations of manual assessment. A mechanical frame that completely isolates each eye is used, with full-color LED stimulation and real-time high-resolution camera recording of both anterior segments. Detailed information such as dilation velocity and pupil area, which cannot be measured with the naked eye, can be obtained. Devices available in Japan include the Iriscorder Dual C-10641 (dual wavelength selection of blue 470 nm and red 635 nm, simultaneous binocular recording) and the ET-200 (two cameras, three-color multi-color LED).

Differential diagnosis

Differentiation from efferent pathway disorders (oculomotor nerve palsy, traumatic mydriasis) is most important. In efferent pathway disorders, the affected eye is always dilated, and even with indirect light stimulation of the healthy eye, the affected eye does not constrict. In RAPD, both eyes constrict when the healthy eye is stimulated, which is a key difference.
Argyll Robertson pupil: Exhibits light-near dissociation but is bilateral and severely miotic.
Tonic pupil (Adie pupil): Diminished to absent light reflex, preserved near response, and tonic reaction. Shows denervation supersensitivity to 0.125% pilocarpine.

Q Can the degree of RAPD be quantified?

Quantification is possible using the ND filter method. It is expressed by the filter density at which RAPD disappears when placed in front of the healthy eye (e.g., 0.3 log unit), and can also be used to monitor treatment progress. Digital pupillography allows objective quantification using multiple parameters such as dilation velocity and pupil area.

5. Standard treatment

There is no specific treatment for RAPD itself. Treatment is directed at the underlying cause. Prognosis depends on the underlying disease.

Idiopathic Optic Neuritis (Typical Optic Neuritis)

Visual recovery is expected in over 90% of cases. Even without treatment, improvement begins within 3 weeks of onset in about 80% of cases.

Steroid pulse therapy: Intravenous methylprednisolone 1,000 mg/day for 3 days.
Oral prednisone after pulse therapy (maintenance therapy) is not performed (contraindicated due to increased relapse rate).
Oral corticosteroid monotherapy is not performed because it increases the risk of optic neuritis recurrence.
If response is insufficient: consider a second pulse after an interval of 4–5 days.
Exclude infections such as hepatitis B before systemic steroid administration.
If corrected visual acuity is relatively good: oral mecobalamin 1,500 μg/day (off-label) and observation is an option.

Anti-AQP4 Antibody-Positive Optic Neuritis

High resistance to steroid therapy. Treated as part of NMDA spectrum disorder, requiring collaboration with neurology.

MOG-IgG-Associated Optic Neuritis (MOGAD) ²⁾

Acute phase: Intravenous methylprednisolone (IVMP), followed by oral prednisone taper (1–3 months).
If IVMP is ineffective: plasma exchange or IVIG.
Long-term immunotherapy: Limited to recurrent cases. Rituximab, azathioprine, mycophenolate mofetil, or monthly IVIG (may have greatest relapse reduction effect).
About half of cases recur, but visual recovery is generally good (poor prognosis of 20/200 or worse in 5–14%).

Infectious Optic Neuritis

For syphilis and other infections, antibiotics are prioritized over steroids.

Orbital Compartment Syndrome³⁾

RAPD-positive plus visual loss is an indication for emergency decompression. Lateral canthotomy and inferior cantholysis are performed. If the hematoma is localized, image-guided surgical drainage may be necessary.

Q Is there a medication to treat RAPD itself?

RAPD is not a disease itself but a “sign” reflecting the degree of optic nerve or retinal damage; therefore, there is no specific treatment for RAPD itself. The principle is to diagnose the underlying cause and provide corresponding treatment (e.g., steroid pulse therapy for optic neuritis).

6. Pathophysiology and Detailed Mechanisms

Neural Circuit of the Pupillary Light Reflex

Afferent pathway: Retina → optic nerve → optic chiasm (bifurcates to ipsilateral and contralateral sides) → leaves the main visual pathway before the lateral geniculate body → pretectal nucleus in the midbrain → bilateral Edinger-Westphal nuclei (EW nuclei)
Efferent pathway: EW nucleus → oculomotor nerve → ciliary ganglion → short ciliary nerves → sphincter pupillae muscle → miosis

Mechanism of RAPD

If the amount of pupillary constriction when stimulating one eye is less than when stimulating the other eye, it indicates a difference in visual input between the two eyes. Since the direct and consensual responses are nearly equal, anisocoria does not occur under binocular viewing. The difference in response between the affected and healthy sides becomes apparent only with alternating stimulation.

Optic Chiasm and Optic Tract Relationship

In the optic chiasm, crossing fibers (approximately 53%) outnumber non-crossing fibers. Lesions of the optic tract can cause mild RAPD in the contralateral eye. In homonymous hemianopia due to optic tract damage, RAPD occurs in the eye with temporal visual field loss (nasal retina = temporal visual field = crossing fibers).

Dissociation from Near Response

The supranuclear fibers to the Edinger-Westphal nucleus for near response run more ventrally than the afferent fibers for the light reflex. The ratio of neurons for light reflex to accommodation in the ciliary ganglion is 3:97, so even if the light reflex is impaired, pupillary constriction due to near response is often preserved.

Pathophysiology of Each Causative Disease (Overview)

Demyelinating optic neuritis: Destruction of the myelin sheath impairs neural conduction in the optic nerve.
Anti-AQP4 antibody-positive optic neuritis: Antibody plus complement attack astrocytes. Astrocytes in the optic nerve and chiasm highly express AQP4.
MOGAD: MOG-IgG targets myelin oligodendrocyte glycoprotein ²⁾.
Ischemic optic neuropathy: Axonal degeneration due to impaired blood flow to the optic nerve.
Compressive optic neuropathy: Axonal damage and myelin injury due to physical compression.

7. Latest Research and Future Perspectives (Research-stage Reports)

Advances in Digital Pupillometry

Digital pupillography using infrared video devices eliminates the limitations of traditional manual testing (examiner bias, subjectivity, reproducibility) and provides objective quantification, recording, and improved follow-up quality for RAPD. With the development of personal computer-based systems, precise pupillometry, previously only possible at specialized institutions, is becoming available in general clinical settings.

Elucidation of MOG-IgG-Associated Disease (MOGAD)²⁾

MOGAD is being established as a disease entity independent of MS and anti-AQP4 antibody-positive NMOSD. Optic neuritis is the most common initial symptom in adults, and headache precedes attacks in about half of cases. Persistent MOG-IgG positivity may be a predictor of relapse, but transient positivity carries a low risk of relapse. Optimal long-term immunotherapy has not been established, and international prospective studies are ongoing.

8. References

Shahrudin NFH, Muhammed J, Wan Hitam WH. Infiltrative Optic Neuropathy in Advanced Breast Carcinoma. Cureus. 2023;15(12):e50994.
Leishangthem L, Beres S, Moss HE, Chen JJ. A Tearfully Painful Darkness. Surv Ophthalmol. 2021;66(3):543-549.
Hurley DJ, Murphy R, Farrell S. Spontaneous postpartum lateral rectus haemorrhage. BMJ Case Rep. 2022;15:e248133.
Jojo V, Singh P, Samanta RP, Ahmad R. Unilateral Choroidal Granuloma and a Pupillary Abnormality in a Case of Miliary Tuberculosis: A Dilemma for the Physician. Cureus. 2022;14(9):e28713.

Related keywords